Cafepharma Today

January 30 2025 - Novo Nordisk commences fresh trials for CagriSema
Novo Nordisk commences fresh trials for CagriSema
Express Scripts becomes latest PBM to follow in Mark Cuban's footsteps
With efficacy assured, Merck halts another trial of blockbuster-to-be Winrevair
Sanofi plans €5 billion buyback, sees higher profit growth
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Auxilium Q4 net loss widens
Pharmaceutical Business Review
Monday, February 23, 2009 - 7:35am
tags:
Auxilium, earnings
Shire looks at Japanese expansion and deals elsewhere
Phama Times, UK
Monday, February 23, 2009 - 7:16am
tags:
Shire, Japan
Cell Therapeutics Sells Rest of Zevalin Stake
TheStreet.com
Monday, February 23, 2009 - 7:15am
tags:
Cell Therapeutics, Zevalin, Spectrum Pharmaceuticals
Is Pharmacyclics Eying China?
Seeking Alpha
Monday, February 23, 2009 - 7:14am
tags:
China, Pharmacyclics
J&J's Weldon Turns Down Merit Raise
WSJ Online
Monday, February 23, 2009 - 7:13am
tags:
JNJ, William Weldon
Abbott Labs: Powerful Company with a Bright Future
Seeking Alpha
Monday, February 23, 2009 - 7:12am
tags:
Abbott Laboratories
Sun and Taro CEOs in direct compromise talks
Globes, Israel
Sunday, February 22, 2009 - 10:45am
tags:
Sun Pharma, Taro
China Biotech in Review: Investments Continue
Seeking Alpha
Sunday, February 22, 2009 - 10:40am
tags:
China, biotech
Daiichi Sankyo to launch flu preventive drug-Nikkei
Reuters
Sunday, February 22, 2009 - 10:37am
tags:
Daiichi Sankyo
Eisai Signs License Agreement in Europe for an Anti-epileptic Drug
Pipeline Review
Sunday, February 22, 2009 - 10:32am
tags:
Eisai
Raptiva: An Itch That Can Kill
Lawyers and Settlements
Sunday, February 22, 2009 - 10:29am
tags:
Raptiva, Genentech
Abbott Offers a Safe Haven In the Drug-Stock Turmoil
Wall Street Journal
Sunday, February 22, 2009 - 10:24am
tags:
Abbott Laboratories
Ariad to raise $24M through stock offering
bizjournals.com
Sunday, February 22, 2009 - 10:21am
tags:
Ariad Pharmaceuticals
Shareholder wants Vanda Pharmaceuticals to shut down
bizjournals.com
Sunday, February 22, 2009 - 10:18am
tags:
Vanda
Cel-Sci unveils plan to raise funds
bizjournals.com
Saturday, February 21, 2009 - 1:06pm
tags:
Cel-Sci
Shareholder wants Vanda Pharmaceuticals to shut down
bizjournals.com
Saturday, February 21, 2009 - 1:05pm
tags:
Vanda
Novel Drug May Benefit Patients With Heart Disease
Modern Medicine
Saturday, February 21, 2009 - 12:55pm
tags:
Anthera
AstraZeneca Filling Supply Gap For Blood Pressure Drug
Easy Bourse, France
Saturday, February 21, 2009 - 12:53pm
tags:
AstraZeneca
Auxilium Pharmaceuticals, Inc. Announces Fourth Quarter and Full Year 2008 Financial Results
PR-USA
Saturday, February 21, 2009 - 12:52pm
tags:
Auxilium
La Jolla Pharmaceutical Looks at Sale or “Winding Down”
Xconomy
Saturday, February 21, 2009 - 12:51pm
tags:
La Jolla Pharmaceutical

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Annoying Enzyme Activity
In the Pipeline
Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information